Mirabegron (ER) 25 mg/50 mg and Solifenacin 5 mg/5 mg Tablet

Mirabegron (ER) 25 mg/50 mg and Solifenacin 5 mg/5 mg Tablet
Product Description

Fixed dose combination (FDC) of Mirabegron (Extended release) and Solifenacin tablet can be used for the treatment of overactive bladder and to control the frequent urination. These drugs act together by their distinct mechanism of action that provide clear improvement and reduce side effects of monotherapy (Individual drug therapy).

Read more Show less

Windlas Biotech Limited

  • IN
  • 2022
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
View company profile
Categories
more categories Show less
Specifications
  • Details
    DCGI Approved

More specifications Fewer specifications

Windlas Biotech Limited

  • IN
  • 2022
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
View company profile

More Products from Windlas Biotech Limited (2)